Background and Objectives: Hemoglobinopathies are characterized by defects in the synthesis of globin chains of hemoglobin (Hb). The purpose of the present study was to evaluate mutations associated with thalassemia and other hemoglobinopathies in Masjed Soleiman County, Iran.
predominant ethnic group that resides in the Masjed Soleiman County in the Khuzestan Province, and consanguineous marriage is a common custom among this ethnic group. In this study, we aimed to evaluate the prevalence of hemoglobinopathies in the Masjed Soleiman, Iran.
MATERIALS AND METHODS
The study included 456 individuals suspected of having anemia and hemoglobinopathies who were referred to health centers of Masjed Soleiman in 2015-2017. Blood samples were collected in EDTA tubes. Screening for hemoglobinopathies included complete blood count, Hb electrophoresis and measurement of Hb A2 level. The standard diagnostic marker for β-thalassemia is elevation of the Hb A2 level (3.5%). Complete blood count was carried out with an automated hematology analyzer (Sysmex KX-21 N, Kobe, Japan). Quantification of Hb A2, Hb F, Hb A and other Hb variants was performed using Sebia Minicap (France) according to the manufacturer's instructions. The Minicap system uses the principle of capillary electrophoresis in free solution and automatically produces one electropherogram (9). Genomic DNA was extracted from whole blood leukocytes using the QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany). Reverse dot-blot hybridization analysis was performed using β-Globin Strip Assay SEA™ (ViennaLab Diagnostics, Vienna, Austria) according to the manufacturer's instructions to screen for common β-globin gene mutations. The results were then validated with amplification refractory mutation systempolymerase chain reaction (ARMS-PCR) (10). For this purpose, primers were designed according to previous studies (4, 11) . In patients without mutation, Sanger sequencing was performed to identify undetected mutations. DNA was amplified by PCR using specific primers as described by Galehdari et al., and PCR products were sequenced with an ABI 3730 DNA analyzer (Applied Biosystems Inc., CA, USA) (12). Individuals with low mean corpuscular volume (MCV80.0 fL), mean cell Hb (MCH) of less than 27.0 pg, normal Hb A2 and normal iron levels were suspected to be -thalassemia carriers.
INTRODUCTION
Hemoglobinopathies are among the most prevalent inherited disorders around the world. The hemoglobin (Hb) molecule in humans is made up of two pairs of unlike globin chains designated as α, β, γ and δ (1). Hb disorders are classified into thalassemia syndromes (α-and β-thalassemia) and structural Hb variants. Approximately 7% of the world's population carry an abnormal Hb gene, and about 300,000-500,000 infants are born with clinically significant Hb disorders every year (2). Thalassemia is more prevalent in the Mediterranean region, North and West Africa, the Middle East, the Indian subcontinent, southern Far East and southeastern Asia. Iran is a high-incidence region for β-thalassemia, but the incidence rates vary from one area to another. For instance, the prevalence of β-thalassemia trait is above 10% near the Caspian Sea and the Persian Gulf and about 4-8% in other areas of Iran (3). B-thalassemia results from mutations in the HBB gene cluster which is located on the short arm of chromosome. More than 300 β-thalassemia-causing mutations and 1,000 Hb variants have been identified(http://globin.cse.psu.edu/hbvar/men u.html). In Iran, there are about 25,000 β-thalassemia patients and 2 million carriers (4). In addition, 50 different mutations have been detected in different populations of Iran. According to studies, the prevalence of β-thalassemia is higher in the northern parts of Iran (4, 5) . Abnormal manufacturing or absent of α-globin chains causes α-thalassemia. The α-globin gene loci are duplicated (αα/αα). Α-thalassemia carriers are individuals without the two α-globin genes (--/αα or -α/-α) that have smaller red blood cell (RBCs) and a lower RBC count (mild anemia). However, loss of three α-globin genes (--/-α) results in Hb H disease. Hb Bart's hydrops fetalis syndrome is caused by deletion of all four α-globin genes (6). Structural Hb variants result from point mutations in the α-or β-globin genes. The most widespread variants in the world are Hb S, Hb C, Hb E and Hb D-Punjab (7). Different ethnic groups and tribes live in the Khuzestan Province, Iran. It has been reported that the prevalence of α-and β-thalassemia as well as Hb S, Hb C and Hb D is high in this province (8 20.5 (1.5%) deletions were also detected in the suspected cases (figure 1), and no mutation was found in 12 cases. 
RESULTS
Among the 456 subjects, 81 subjects (17.7%) had low MCV and MCH levels and Hb A2 of less than 3.5%, and thus were identified as β-thalassemia carriers. It was found that 8.4% of individuals were heterozygous for Hb S, Hb D, Hb C and Hb Barts. In addition, 1.1% of the subjects showed co-inheritance of an Hb variant and β-thalassemia. Hb S is produced by a point mutation in the HBB gene. Clinical features of Hb S-β thalassemia are variable, ranging from a completely asymptomatic state to a severe disorder that is similar to homozygous sickle cell disease. The prevalence of this condition is high in south of Iran, particularly the Khuzestan Province (16) . Hb D is a β-chain variant that is mainly found in northwest India, Pakistan and Iran (17). It may be co-inherited with Hb S or β-thalassemia. The co-inheritance of β-thalassemia and Hb D can result in a slightly lower Hb level.
DISCUSSION
Hemoglobinopathies include thalassemia and structural variants of Hb (Hb S, Hb C and Hb E) that result from defects in the synthesis of the globin chains. Iran is a multi-ethnic state that shows heterogeneity in Hb variants and thalassemia mutations. The Khuzestan Province in southeast of Iran also encompasses various ethnic groups including Arab, Persian, Bakhtiari and Lurs, and has a high prevalence of α-and β-thalassemia mutations (19). So far, 42 different β-thalassemia mutations and several common β-globin variants including, Hb S, Hb C Hb D-Punjab Hb O-Arab, Hb E and Hb J-Iran have been identified (4, 8, 12, 15, 16 (24) . In Iran, the most common mutation are −α 3.7 , -α 4.2 , -α 20.5 and --MED deletions (16, 28, 29) . In a study by Khosravi et al., the -a 3.7 and --MED deletions were reported as the most common mutations in the Bakhtiari population of the Khuzestan Province (30). Hossieni Nejad et al. conducted a study on -and -globin gene mutations in Abadan and Khorramshahr (Khuzestan Province) and reported IVSII-I as the most prevalent mutation (31) , which is inconsistent with our findings. Similar to our study, a study in city of Shadegan (Khuzestan Province) detected CD 36/37(-T) (38.61%) and -α3.7/αα (52.99%) as the most common mutations among -thalassemia and -thalassemia carriers, respectively (32). In study of Sayahi et al. on spectrum of thalassemia among voluntary couples in city of Shushtar, CD 36/37 (-T), IVSII-1 (G>A) and IVSI-110 (G>A) were identified as the most common mutations (33) . In this study, we used capillary zone electrophoresis for the detection of hemoglobinopathies. Joshaghani et al. used the same technique for detection of Hb abnormalities in north of Iran, and identified the Hb S (55%), Hb H (27%), Hb Barts (41%), Hb D (4.68%) and Hb E (2.7%) variants (34). These findings are in line with our results except for the Hb E, which was not detected in our subjects.
CONCLUSION
In addition to the high prevalence of β-thalassemia and HBB gene mutations, we detected Hb variants Hb S, Hb D, Hb C and co-inheritance of Hb variants and β-thalassemia in individuals from the Masjed Soleiman Country in the Khuzestan Province, Iran. We also identified four mutations in the α-globin gene. These results can be useful for genetic counseling in this population.
